Avacta Group Plc Stock Net Income
| AVCTF Stock | USD 0.74 0.04 5.13% |
As of the 28th of January, Avacta Group shows the mean deviation of 1.61, and Risk Adjusted Performance of (0.08). Avacta Group Plc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Avacta Group Plc standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if Avacta Group Plc is priced correctly, providing market reflects its regular price of 0.74 per share. As Avacta Group Plc is a penny stock we also strongly suggest to validate its jensen alpha numbers.
Avacta Group's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Avacta Group's valuation are provided below:Avacta Group Plc does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Avacta |
Avacta Group 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Avacta Group's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Avacta Group.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Avacta Group on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Avacta Group Plc or generate 0.0% return on investment in Avacta Group over 90 days. Avacta Group is related to or competes with BioInvent International, Healios KK, MedinCell, PureTech Health, Northwest Biotherapeutics, Immutep, and Cellectis. Avacta Group Plc offers reagents and therapeutics based on Affimer technology for diagnostic and research applications i... More
Avacta Group Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Avacta Group's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Avacta Group Plc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 35.79 | |||
| Value At Risk | (5.13) | |||
| Potential Upside | 1.03 |
Avacta Group Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avacta Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Avacta Group's standard deviation. In reality, there are many statistical measures that can use Avacta Group historical prices to predict the future Avacta Group's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.44) | |||
| Total Risk Alpha | (0.82) | |||
| Treynor Ratio | 1.72 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Avacta Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Avacta Group January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | 1.73 | |||
| Mean Deviation | 1.61 | |||
| Coefficient Of Variation | (845.29) | |||
| Standard Deviation | 3.81 | |||
| Variance | 14.54 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.44) | |||
| Total Risk Alpha | (0.82) | |||
| Treynor Ratio | 1.72 | |||
| Maximum Drawdown | 35.79 | |||
| Value At Risk | (5.13) | |||
| Potential Upside | 1.03 | |||
| Skewness | (2.47) | |||
| Kurtosis | 19.42 |
Avacta Group Plc Backtested Returns
Avacta Group Plc secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12 % return per unit of standard deviation over the last 3 months. Avacta Group Plc exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Avacta Group's mean deviation of 1.61, and Risk Adjusted Performance of (0.08) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.27, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Avacta Group are expected to decrease at a much lower rate. During the bear market, Avacta Group is likely to outperform the market. At this point, Avacta Group Plc has a negative expected return of -0.49%. Please make sure to confirm Avacta Group's standard deviation and the relationship between the total risk alpha and price action indicator , to decide if Avacta Group Plc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.09 |
Virtually no predictability
Avacta Group Plc has virtually no predictability. Overlapping area represents the amount of predictability between Avacta Group time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Avacta Group Plc price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Avacta Group price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Avacta Group Plc reported net income of (26.32 Million). This is 107.71% lower than that of the Healthcare sector and 137.57% lower than that of the Biotechnology industry. The net income for all United States stocks is 104.61% higher than that of the company.
Avacta Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avacta Group's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Avacta Group could also be used in its relative valuation, which is a method of valuing Avacta Group by comparing valuation metrics of similar companies.Avacta Group is currently under evaluation in net income category among its peers.
Avacta Fundamentals
| Return On Equity | -0.56 | |||
| Return On Asset | -0.32 | |||
| Operating Margin | (3.85) % | |||
| Current Valuation | 332.42 M | |||
| Shares Outstanding | 269.87 M | |||
| Shares Owned By Insiders | 35.05 % | |||
| Shares Owned By Institutions | 13.42 % | |||
| Price To Book | 7.68 X | |||
| Price To Sales | 49.44 X | |||
| Revenue | 2.94 M | |||
| Gross Profit | (947 K) | |||
| EBITDA | (26.69 M) | |||
| Net Income | (26.32 M) | |||
| Cash And Equivalents | 26.19 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 1.7 M | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 7.95 X | |||
| Book Value Per Share | 0.14 X | |||
| Cash Flow From Operations | (20.51 M) | |||
| Earnings Per Share | (0.13) X | |||
| Number Of Employees | 133 | |||
| Beta | 1.61 | |||
| Market Capitalization | 613.71 M | |||
| Total Asset | 47 M | |||
| Net Asset | 47 M |
About Avacta Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avacta Group Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avacta Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avacta Group Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Avacta Pink Sheet
Avacta Group financial ratios help investors to determine whether Avacta Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avacta with respect to the benefits of owning Avacta Group security.